ARIPRA aripiprazole 10 mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

aripiprazole, Quantity: 10 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

aripiprazole

Forma farmaceutica:

Tablet, uncoated

Composizione:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Via di somministrazione:

Oral

Confezione:

30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Dettagli prodotto:

Visual Identification: 8mm x 5 mm, capsule shaped, biconvex, white uncoated tablets with 10 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-10-29